Totient, an AI-driven drug discovery platform, raised $10 million in a seed funding round. Investors include Mission BioCapital, Sands Capital, Viva Biotech,…
Totient, an AI-driven drug discovery platform, raised $10 million in a seed funding round. Investors include Mission BioCapital, Sands Capital, Viva Biotech,…